chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Abdominal pain upper
Clinical narrative: Very severe stomach pain; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Very severe stomach pain) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL PAIN UPPER (Very severe stomach pain). At the time of the report, ABDOMINAL PAIN UPPER (Very severe stomach pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Dizziness, Fatigue
Clinical narrative: Light headedness; Fatigue; sore left shoulder; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Light headedness), ARTHRALGIA (sore left shoulder) and FATIGUE (Fatigue) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 25-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Jun-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced ARTHRALGIA (sore left shoulder). On an unknown date, the patient experienced DIZZINESS (Light headedness) and FATIGUE (Fatigue). On 01-Jul-2021, ARTHRALGIA (sore left shoulder) had resolved. At the time of the report, DIZZINESS (Light headedness) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication information was provided. No treatment medication were provided.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site induration, Vaccination site warmth
Clinical narrative: Very hot to the touch; At the injection site there is really hard section of her upper arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Very hot to the touch) and VACCINATION SITE INDURATION (At the injection site there is really hard section of her upper arm) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jul-2021, the patient experienced VACCINATION SITE WARMTH (Very hot to the touch) and VACCINATION SITE INDURATION (At the injection site there is really hard section of her upper arm). At the time of the report, VACCINATION SITE WARMTH (Very hot to the touch) and VACCINATION SITE INDURATION (At the injection site there is really hard section of her upper arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was reported.  Events had gotten worse rather than better was noted.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Dyspnoea, Illness, Pulmonary pain
Clinical narrative: Pain in lungs, side of lungs to back of lungs; Symptoms started right after the first shot, within a couple hours started in stomach region, mid abdominal area, left side/Felt really sick on first shot, pain settled on left side; Hard to breathe, started after getting the vaccine; Felt really sick on first shot, pain settled on left side; This spontaneous case was reported by a consumer and describes the occurrence of PULMONARY PAIN (Pain in lungs, side of lungs to back of lungs), ABDOMINAL PAIN UPPER (Symptoms started right after the first shot, within a couple hours started in stomach region, mid abdominal area, left side/Felt really sick on first shot, pain settled on left side), DYSPNOEA (Hard to breathe, started after getting the vaccine) and ILLNESS (Felt really sick on first shot, pain settled on left side) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PULMONARY PAIN (Pain in lungs, side of lungs to back of lungs), ABDOMINAL PAIN UPPER (Symptoms started right after the first shot, within a couple hours started in stomach region, mid abdominal area, left side/Felt really sick on first shot, pain settled on left side), DYSPNOEA (Hard to breathe, started after getting the vaccine) and ILLNESS (Felt really sick on first shot, pain settled on left side). At the time of the report, PULMONARY PAIN (Pain in lungs, side of lungs to back of lungs), ABDOMINAL PAIN UPPER (Symptoms started right after the first shot, within a couple hours started in stomach region, mid abdominal area, left side/Felt really sick on first shot, pain settled on left side), DYSPNOEA (Hard to breathe, started after getting the vaccine) and ILLNESS (Felt really sick on first shot, pain settled on left side) had not resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medication reported. No treatment information was provided. Patient has not received medical care due to lack of insurance and was concern about not being able to pay. The patient's mother inquired if there was any medicine available that the patient could take for pain.   This case was linked to MOD-2021-278329 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: side effect; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (side effect) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (side effect). At the time of the report, VACCINATION COMPLICATION (side effect) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia
Clinical narrative: chills; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills) and MYALGIA (Body aches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (chills) and MYALGIA (Body aches). At the time of the report, CHILLS (chills) and MYALGIA (Body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitants provided. No treatment information provided.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Received the first vaccine 3/31/21 but never got the second; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Received the first vaccine 3/31/21 but never got the second) in an 18-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Received the first vaccine 3/31/21 but never got the second). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Received the first vaccine 3/31/21 but never got the second) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details provided.   Reporter did not allow further contact
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Neither of them received the second dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Neither of them received the second dose) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Neither of them received the second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Neither of them received the second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment information was reported
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Nausea, Vomiting
Clinical narrative: Dizziness; vomiting; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), VOMITING (vomiting) and NAUSEA (Nausea) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 088B21A) for COVID-19 vaccination.     Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) and NORETHISTERONE (NORLYDA) for an unknown indication.    On 04-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Aug-2021, the patient experienced DIZZINESS (Dizziness), VOMITING (vomiting) and NAUSEA (Nausea). The patient was treated with PARACETAMOL (TYLENOL) on 05-Aug-2021 at a dose of 1 dosage form. At the time of the report, DIZZINESS (Dizziness), VOMITING (vomiting) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: Significant follow-up appended, added primary reporter information, patient details, concomitant medications, treatment medication and events start date.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received a dose of the vaccine from a vial that was punctured and stored for greater than 12 hours; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 05-Aug-2021 and was forwarded to the company on 05-Aug-2021.    This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received a dose of the vaccine from a vial that was punctured and stored for greater than 12 hours) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040C21A) for COVID-19 vaccination.     No medical history information was reported.     On 31-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received a dose of the vaccine from a vial that was punctured and stored for greater than 12 hours). On 31-Jul-2021, EXPIRED PRODUCT ADMINISTERED (Patient received a dose of the vaccine from a vial that was punctured and stored for greater than 12 hours) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications  were reported. No information details were provided   Most recent FOLLOW-UP information incorporated above includes: On 12-Aug-2021: Non Significant Follow up appended -Contact details updated
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Inflammation, Mass, Pain in extremity, Vaccination complication
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (reaction under the left arm), INFLAMMATION (it got inflamed), MASS (had like a ball under the arm that was quite big, arm still has like a ball that never left, the size of half a ping pong ball, like something that fits your hand.) and PAIN IN EXTREMITY (pain in the arm at the time of the reaction) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (reaction under the left arm), INFLAMMATION (it got inflamed), MASS (had like a ball under the arm that was quite big, arm still has like a ball that never left, the size of half a ping pong ball, like something that fits your hand) and PAIN IN EXTREMITY (pain in the arm at the time of the reaction). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION COMPLICATION (reaction under the left arm), INFLAMMATION (it got inflamed), MASS (had like a ball under the arm that was quite big, arm still has like a ball that never left, the size of half a ping pong ball, like something that fits your hand) and PAIN IN EXTREMITY (pain in the arm at the time of the reaction) outcome was unknown. No concomitant medications reported. Patient reported going to a medical center and received poor and bad medical attention.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Blood creatine increased, Blood pressure decreased, Blood pressure measurement, Dehydration, Diarrhoea
Clinical narrative: diarrhea; Dehydration; blood presser 60/44; while sitting in a chair fell out of it and had to go to the hospital; creatine levels in kidney was 4 times higher; felt like had flu; then woke up in the middle of the night soaked; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of INFLUENZA LIKE ILLNESS (felt like had flu), BLOOD CREATINE INCREASED (creatine levels in kidney was 4 times higher), DIARRHOEA (diarrhea), DEHYDRATION (Dehydration) and BLOOD PRESSURE DECREASED (blood presser 60/44) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006D21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 31-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jul-2021, the patient experienced INFLUENZA LIKE ILLNESS (felt like had flu) and NIGHT SWEATS (then woke up in the middle of the night soaked). On 01-Aug-2021, the patient experienced BLOOD CREATINE INCREASED (creatine levels in kidney was 4 times higher), DEHYDRATION (Dehydration), BLOOD PRESSURE DECREASED (blood presser 60/44) and FALL (while sitting in a chair fell out of it and had to go to the hospital). On 02-Aug-2021, the patient experienced DIARRHOEA (diarrhea). The patient was treated with NORMAL SALINE for Adverse event, at a dose of 5 bags and OXYGEN for Adverse event, at an unspecified dose and frequency. On 02-Aug-2021, BLOOD CREATINE INCREASED (creatine levels in kidney was 4 times higher), DEHYDRATION (Dehydration) and BLOOD PRESSURE DECREASED (blood presser 60/44) had resolved. On 03-Aug-2021, DIARRHOEA (diarrhea) had resolved. At the time of the report, INFLUENZA LIKE ILLNESS (felt like had flu), FALL (while sitting in a chair fell out of it and had to go to the hospital) and NIGHT SWEATS (then woke up in the middle of the night soaked) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Aug-2021, Blood creatine increased: 4 times higher (High) creatine levels in kidney was 4 times higher. On 02-Aug-2021, Blood pressure measurement: 60/44 (Low) 60/44.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Fall, Influenza like illness, Night sweats
Clinical narrative: diarrhea; Dehydration; blood presser 60/44; while sitting in a chair fell out of it and had to go to the hospital; creatine levels in kidney was 4 times higher; felt like had flu; then woke up in the middle of the night soaked; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of INFLUENZA LIKE ILLNESS (felt like had flu), BLOOD CREATINE INCREASED (creatine levels in kidney was 4 times higher), DIARRHOEA (diarrhea), DEHYDRATION (Dehydration) and BLOOD PRESSURE DECREASED (blood presser 60/44) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006D21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 31-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jul-2021, the patient experienced INFLUENZA LIKE ILLNESS (felt like had flu) and NIGHT SWEATS (then woke up in the middle of the night soaked). On 01-Aug-2021, the patient experienced BLOOD CREATINE INCREASED (creatine levels in kidney was 4 times higher), DEHYDRATION (Dehydration), BLOOD PRESSURE DECREASED (blood presser 60/44) and FALL (while sitting in a chair fell out of it and had to go to the hospital). On 02-Aug-2021, the patient experienced DIARRHOEA (diarrhea). The patient was treated with NORMAL SALINE for Adverse event, at a dose of 5 bags and OXYGEN for Adverse event, at an unspecified dose and frequency. On 02-Aug-2021, BLOOD CREATINE INCREASED (creatine levels in kidney was 4 times higher), DEHYDRATION (Dehydration) and BLOOD PRESSURE DECREASED (blood presser 60/44) had resolved. On 03-Aug-2021, DIARRHOEA (diarrhea) had resolved. At the time of the report, INFLUENZA LIKE ILLNESS (felt like had flu), FALL (while sitting in a chair fell out of it and had to go to the hospital) and NIGHT SWEATS (then woke up in the middle of the night soaked) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Aug-2021, Blood creatine increased: 4 times higher (High) creatine levels in kidney was 4 times higher. On 02-Aug-2021, Blood pressure measurement: 60/44 (Low) 60/44.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia, Vaccination site erythema, Vaccination site swelling
Clinical narrative: Swelled up  4" X 2" around Left Arm Injection Site; Red 4" X 2" around Left Arm Injection Site; Feverish  Left  Arm; Sore Left Arm Injection Site; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Sore Left Arm Injection Site), VACCINATION SITE SWELLING (Swelled up  4" X 2" around Left Arm Injection Site), VACCINATION SITE ERYTHEMA (Red 4" X 2" around Left Arm Injection Site) and PYREXIA (Feverish  Left  Arm) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jul-2021, the patient experienced MYALGIA (Sore Left Arm Injection Site). On 05-Aug-2021, the patient experienced VACCINATION SITE SWELLING (Swelled up  4" X 2" around Left Arm Injection Site), VACCINATION SITE ERYTHEMA (Red 4" X 2" around Left Arm Injection Site) and PYREXIA (Feverish  Left  Arm). At the time of the report, MYALGIA (Sore Left Arm Injection Site), VACCINATION SITE SWELLING (Swelled up  4" X 2" around Left Arm Injection Site), VACCINATION SITE ERYTHEMA (Red 4" X 2" around Left Arm Injection Site) and PYREXIA (Feverish  Left  Arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was provided by the Reporter. The treatment information was unknown.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Felt so sick for twelve hours after receiving second dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Felt so sick for twelve hours after receiving second dose) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Felt so sick for twelve hours after receiving second dose). At the time of the report, VACCINATION COMPLICATION (Felt so sick for twelve hours after receiving second dose) outcome was unknown.            Concomitant medication was not provided. Treatment information was not provided.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain
Clinical narrative: Pain on right side of body; Fatigue; Headache; This case was received via  Medicines Agency (Reference number: 126972   ) on 05-Aug-2021 and was forwarded to Moderna on 05-Aug-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain on right side of body), FATIGUE (Fatigue) and HEADACHE (Headache) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Dec-2020, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Dec-2020, the patient experienced PAIN (Pain on right side of body), FATIGUE (Fatigue) and HEADACHE (Headache). At the time of the report, PAIN (Pain on right side of body), FATIGUE (Fatigue) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.   This case was linked to MOD-2021-278399 (Patient Link).
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Pyrexia, Vaccination site pain
Clinical narrative: she felt bad; fever; pain at the injection site; chills/ shivers; This spontaneous case was reported by a pharmacist and describes the occurrence of FEELING ABNORMAL (she felt bad), PYREXIA (fever), VACCINATION SITE PAIN (pain at the injection site) and CHILLS (chills/ shivers) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (she felt bad), PYREXIA (fever), VACCINATION SITE PAIN (pain at the injection site) and CHILLS (chills/ shivers). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form four times per week. At the time of the report, FEELING ABNORMAL (she felt bad), PYREXIA (fever), VACCINATION SITE PAIN (pain at the injection site) and CHILLS (chills/ shivers) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant drug reported
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Confusional state, Electrocardiogram, Fatigue, Feeling abnormal
Clinical narrative: Unable to sleep; brain fog; confusion; muscle aches; Fatigue/exhaustion; headaches; This spontaneous case was reported by a physician and describes the occurrence of INSOMNIA (Unable to sleep), FEELING ABNORMAL (brain fog), CONFUSIONAL STATE (confusion), MYALGIA (muscle aches) and FATIGUE (Fatigue/exhaustion) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022c21a and 022c21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Grass allergy, Dust allergy and Allergy to plants. Concomitant products included FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF) from 01-Jan-2000 to an unknown date and LEVOCETIRIZINE DIHYDROCHLORIDE (XYZAL) from 01-Jan-2000 to an unknown date for Allergy, ALBUTEROL SULFATE from 01-Jan-2000 to an unknown date for Asthma NOS, ONE A DAY WOMEN'S from 01-Jan-2000 to an unknown date for Vitamin supplementation, RUBUS IDAEUS LEAF, SAMBUCUS NIGRA FLOWER, SAMBUCUS NIGRA FRUIT (ELDERBERRY [RUBUS IDAEUS LEAF;SAMBUCUS NIGRA FLOWER;SAMBUCUS NIGRA FRUIT]) from 25-Feb-2021 to an unknown date for Zinc supplementation.   On 04-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INSOMNIA (Unable to sleep), FEELING ABNORMAL (brain fog), CONFUSIONAL STATE (confusion), MYALGIA (muscle aches), FATIGUE (Fatigue/exhaustion) and HEADACHE (headaches). At the time of the report, INSOMNIA (Unable to sleep), FEELING ABNORMAL (brain fog), CONFUSIONAL STATE (confusion), MYALGIA (muscle aches), FATIGUE (Fatigue/exhaustion) and HEADACHE (headaches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Feb-2021, SARS-CoV-2 test: positive (Positive) Positive. On an unknown date, Blood test: normal (normal) Normal. On an unknown date, Electrocardiogram: normal (normal) Normal.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It was reported that, the patient was struggling, can't work, can't live life and no one knows what to do to help the patient.  No treatment medications were reported.   This case was linked to MOD-2021-214782 (Patient Link).
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Insomnia, Myalgia, SARS-CoV-2 test
Clinical narrative: Unable to sleep; brain fog; confusion; muscle aches; Fatigue/exhaustion; headaches; This spontaneous case was reported by a physician and describes the occurrence of INSOMNIA (Unable to sleep), FEELING ABNORMAL (brain fog), CONFUSIONAL STATE (confusion), MYALGIA (muscle aches) and FATIGUE (Fatigue/exhaustion) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022c21a and 022c21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Grass allergy, Dust allergy and Allergy to plants. Concomitant products included FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF) from 01-Jan-2000 to an unknown date and LEVOCETIRIZINE DIHYDROCHLORIDE (XYZAL) from 01-Jan-2000 to an unknown date for Allergy, ALBUTEROL SULFATE from 01-Jan-2000 to an unknown date for Asthma NOS, ONE A DAY WOMEN'S from 01-Jan-2000 to an unknown date for Vitamin supplementation, RUBUS IDAEUS LEAF, SAMBUCUS NIGRA FLOWER, SAMBUCUS NIGRA FRUIT (ELDERBERRY [RUBUS IDAEUS LEAF;SAMBUCUS NIGRA FLOWER;SAMBUCUS NIGRA FRUIT]) from 25-Feb-2021 to an unknown date for Zinc supplementation.   On 04-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INSOMNIA (Unable to sleep), FEELING ABNORMAL (brain fog), CONFUSIONAL STATE (confusion), MYALGIA (muscle aches), FATIGUE (Fatigue/exhaustion) and HEADACHE (headaches). At the time of the report, INSOMNIA (Unable to sleep), FEELING ABNORMAL (brain fog), CONFUSIONAL STATE (confusion), MYALGIA (muscle aches), FATIGUE (Fatigue/exhaustion) and HEADACHE (headaches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Feb-2021, SARS-CoV-2 test: positive (Positive) Positive. On an unknown date, Blood test: normal (normal) Normal. On an unknown date, Electrocardiogram: normal (normal) Normal.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It was reported that, the patient was struggling, can't work, can't live life and no one knows what to do to help the patient.  No treatment medications were reported.   This case was linked to MOD-2021-214782 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: COVID-19, Vaccination complication
Clinical narrative: 15 people in her immediate family who are experiencing adverse effects from the vaccine; 5 people who have had the vaccine and got COVID, and their COVID is worse than if they did not have the vaccine.; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (15 people in her immediate family who are experiencing adverse effects from the vaccine) and COVID-19 (5 people who have had the vaccine and got COVID, and their COVID is worse than if they did not have the vaccine.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (15 people in her immediate family who are experiencing adverse effects from the vaccine) and COVID-19 (5 people who have had the vaccine and got COVID, and their COVID is worse than if they did not have the vaccine.). At the time of the report, VACCINATION COMPLICATION (15 people in her immediate family who are experiencing adverse effects from the vaccine) and COVID-19 (5 people who have had the vaccine and got COVID, and their COVID is worse than if they did not have the vaccine.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were reported.  No treatment medications were reported.   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm pain). At the time of the report, PAIN IN EXTREMITY (arm pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Amenorrhoea
Clinical narrative: Has not had her period since; This spontaneous case was reported by a consumer and describes the occurrence of AMENORRHOEA (Has not had her period since) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036C21A and 022B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced AMENORRHOEA (Has not had her period since). At the time of the report, AMENORRHOEA (Has not had her period since) outcome was unknown.            No concomitant medications were reported. No treatment information was reported.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Hyperhidrosis, Pain in extremity
Clinical narrative: Really bad sweets, "like I just got out of the shower" ( for 4 days); Initially had pain in his left arm, it went away and came back a week later; Diarrhea every day since the shot; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Really bad sweets, "like I just got out of the shower" ( for 4 days)), PAIN IN EXTREMITY (Initially had pain in his left arm, it went away and came back a week later) and DIARRHOEA (Diarrhea every day since the shot) in a 24-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included FINASTERIDE (PROPECIA) and SERTRALINE HYDROCHLORIDE (ZOLOFT) for an unknown indication.   On 26-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERHIDROSIS (Really bad sweets, "like I just got out of the shower" ( for 4 days)), PAIN IN EXTREMITY (Initially had pain in his left arm, it went away and came back a week later) and DIARRHOEA (Diarrhea every day since the shot). At the time of the report, HYPERHIDROSIS (Really bad sweets, "like I just got out of the shower" ( for 4 days)), PAIN IN EXTREMITY (Initially had pain in his left arm, it went away and came back a week later) and DIARRHOEA (Diarrhea every day since the shot) outcome was unknown.            The treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever; This case was received via Medicines Agency (Reference number: US-irms-MOD21-126672   ) on 05-Aug-2021 and was forwarded to Moderna on 05-Aug-2021.    Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever). At the time of the report, PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications   Treatment details were reported.   Reporter did not allow further contact
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling face
Clinical narrative: Severe face swollen/everything from the neck up is swollen; This case was received via Regulatory Authority (Reference number: US-irms-MOD21-127121) on 05-Aug-2021 and was forwarded to Moderna on 05-Aug-2021.    This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (Severe face swollen/everything from the neck up is swollen) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Aug-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SWELLING FACE (Severe face swollen/everything from the neck up is swollen). At the time of the report, SWELLING FACE (Severe face swollen/everything from the neck up is swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Treatment medication was provided. No Concomitant medication provided.   Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: Upon Follow-up Received : Reporter details added,  Dosage form and product start date added,
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: "dizziness after first dose"; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of DIZZINESS ("dizziness after first dose") in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS ("dizziness after first dose"). At the time of the report, DIZZINESS ("dizziness after first dose") outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications are provided by reporter. No treatment medications are provided by reporter.   This case was linked to MOD-2021-278429 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, SARS-CoV-2 test
Clinical narrative: Mild sore throat; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Mild sore throat) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced OROPHARYNGEAL PAIN (Mild sore throat). At the time of the report, OROPHARYNGEAL PAIN (Mild sore throat) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Jul-2021, SARS-CoV-2 test: positive (Positive) tested positive for Covid (variant unknown) on 07/28.         No concomitant medications were reported.  No treatment medications were reported.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (got the second dose more than 36 days apart from the first) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048C21A and 014C21A) for COVID-19 vaccination. No Medical History information was reported. On 04-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Aug-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (got the second dose more than 36 days apart from the first). On 03-Aug-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (got the second dose more than 36 days apart from the first) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were reported. No treatment medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 08-Sep-2021: non-significant follow up appended - Reporter's Contact information updated. On 08-Sep-2021: non-significant follow up received on 08-Sep-2021 includes NNI.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Vaccination adverse reaction; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Vaccination adverse reaction) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Vaccination adverse reaction). At the time of the report, VACCINATION COMPLICATION (Vaccination adverse reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Product dose omission issue, Pyrexia, Rash
Clinical narrative: Bad rash; Fever; Chills; Did not get her second dose yet; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Bad rash), PYREXIA (Fever), CHILLS (Chills) and PRODUCT DOSE OMISSION ISSUE (Did not get her second dose yet) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 07-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (Bad rash), PYREXIA (Fever), CHILLS (Chills) and PRODUCT DOSE OMISSION ISSUE (Did not get her second dose yet). At the time of the report, RASH (Bad rash), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (Did not get her second dose yet) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported. No treatment information was provided.   Reporter did not allow further contact
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: a staff member accidentally gave the Moderna Covid-19 Vaccine to a 13 year old; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (a staff member accidentally gave the Moderna Covid-19 Vaccine to a 13 year old) in a 13-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Aug-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (a staff member accidentally gave the Moderna Covid-19 Vaccine to a 13 year old). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (a staff member accidentally gave the Moderna Covid-19 Vaccine to a 13 year old) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant and treatment medication was not provided. The patient had no adverse effect from the vaccine.   Most recent FOLLOW-UP information incorporated above includes: On 06-Oct-2021: Information regarding adverse events updated.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: 56 days after the first dose/He received the first dose on 10Jun2021 and the second dose on 05Aug2021; This spontaneous case was reported by an other health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (56 days after the first dose/He received the first dose on 10Jun2021 and the second dose on 05Aug2021) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Aug-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (56 days after the first dose/He received the first dose on 10Jun2021 and the second dose on 05Aug2021). On 05-Aug-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (56 days after the first dose/He received the first dose on 10Jun2021 and the second dose on 05Aug2021) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant and treatment drug provided   Reporter did not allow further contact
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Product storage error, Vaccination complication
Clinical narrative: felt sick; Received second dose that had improper storage; dizzy/light headed; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (felt sick), PRODUCT STORAGE ERROR (Received second dose that had improper storage) and DIZZINESS (dizzy/light headed) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.   In April 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (felt sick), PRODUCT STORAGE ERROR (Received second dose that had improper storage) and DIZZINESS (dizzy/light headed). At the time of the report, VACCINATION COMPLICATION (felt sick), PRODUCT STORAGE ERROR (Received second dose that had improper storage) and DIZZINESS (dizzy/light headed) had resolved.            No treatment information was provided by the reporter. No Concomitant medicines were reported.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Getting COVID After the Vaccine; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Getting COVID After the Vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COVID-19 (Getting COVID After the Vaccine). At the time of the report, COVID-19 (Getting COVID After the Vaccine) outcome was unknown.            No concomitant medications  were reported.  NO Treatment medications were reported.